Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Diagnostic intervention: Positron Emission Tomography with 16-alpha-[18-fluoro]-17betaestradiol
OTHER
2 trials
Sponsors
University Medical Center Groningen
Conditions
Breast Cancer
Metastatic Breast Cancer
Phase 2
Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites
Completed
NCT01377324
University Medical Center Groningen
Metastatic Breast Cancer
Start: 2011-05-31
End: 2013-08-31
Updated: 2024-05-06
Unknown Phase
Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
Completed
NCT01088477
University Medical Center Groningen
Breast Cancer
Start: 2010-02-28
End: 2014-02-28
Updated: 2024-05-06
Related Papers
Residual estrogen receptor availability during fulvestrant 500 mg therapy in patients with metastatic breast cancer.
Journal of Clinical Oncology
2014-05-20
1 citations